Autumn Budget: Record £20.4bn R&D investment
In the 2024 Autumn Budget, the UK government announced a landmark investment of £20.4 billion into research and development (R&D) to boost economic growth, tackle national challenges, and establish the UK as a global leader in innovation. This substantial funding demonstrates a commitment to addressing critical areas like healthcare, sustainable energy, digital infrastructure, and technological advancements, aiming to achieve the UK’s “five national missions.” Here’s an overview of the key allocations and expected impacts.
Horizon Europe and Core R&D Budget
A significant portion of the budget secures the UK's full participation in Horizon Europe, the EU's primary research and innovation program. By committing to this association, UK scientists and innovators gain access to an €95 billion fund for collaborative projects, positioning the UK at the heart of global scientific advancements. Additionally, the Department for Science, Innovation, and Technology (DSIT) received a budget increase to £13.9 billion, while core research funding rose to a record £6.1 billion. These increases aim to bolster the UK’s research base and foster innovation across various sectors.
Life Sciences Innovative Manufacturing Fund
The government unveiled a £520 million Life Sciences Innovative Manufacturing Fund (LSIMF) to enhance the UK's capacity for manufacturing critical medical supplies. Starting with an initial £70 million in grants, the LSIMF is expected to unlock up to £1.8 billion in private investment, creating thousands of high-skilled jobs and supporting the healthcare sector’s resilience. This fund aims to strengthen the NHS by ensuring quicker access to innovative treatments, contributing to the UK’s preparedness for future health emergencies.
R&D Missions Programme
A new R&D Missions Programme will initially receive £25 million to address specific national challenges, such as healthcare advancements and clean energy transition. This initiative will foster partnerships with private and third-sector organisations to convert scientific discoveries into practical solutions, enhancing the quality of life and driving forward the UK’s sustainability goals.
Proof of Concept Fund for University Spinouts
To foster innovation from UK universities, the government is investing £40 million over five years in a Proof of Concept Fund. This fund will help researchers transform breakthrough ideas into viable businesses, creating job opportunities and stimulating economic growth. Success stories like Pragmatic Semiconductor and Oxford Nanopore underscore the potential of university spinouts to drive growth, with both companies raising significant investment and creating high-skilled employment in critical sectors.
Innovation Accelerators and Made Smarter Innovation Programs
The budget extends funding for Innovation Accelerators, supporting regional innovation in areas like Glasgow, Greater Manchester, and the West Midlands. These accelerators focus on developing high-potential local industries, with projects like Chemify and the Biochar Cleantech Accelerator attracting millions in private investment. Additionally, the Made Smarter Innovation program will receive £37 million to encourage manufacturers to integrate digital technologies, enhancing productivity and sustainability across UK industries.
Project Gigabit and Shared Rural Network
To improve connectivity, the government will invest £500 million in Project Gigabit and the Shared Rural Network. This funding supports the expansion of high-speed digital infrastructure to underserved regions, with the goal of achieving full gigabit coverage by 2030. Reliable internet access is crucial for businesses and communities across the UK, ensuring equal access to digital resources and fostering regional economic development.
Shared Services Strategy
An £80 million allocation will modernise shared services across nine government departments, streamlining operations for greater efficiency. By updating these systems, the government aims to cut costs and improve services, providing better value for taxpayers.
Barriers to Transformative Technology Adoption
To identify obstacles in adopting transformative technologies, a review led by Chief Scientific Adviser Professor Dame Angela McLean and National Technology Adviser Dr. Dave Smith will assess high-growth sectors. This review seeks to enhance productivity and drive innovation in alignment with the government’s Industrial Strategy, ensuring the UK remains competitive in emerging tech fields.
Reaction from the Scientific Community
This record R&D investment has been met with widespread approval from the scientific community. Royal Society President Sir Adrian Smith commended the government’s recognition of research as a “crucial national asset,” emphasising that protecting the science budget is essential for long-term economic growth. He noted the importance of supporting net-zero initiatives and promoting innovation in sectors like AI to maximise the economic benefits of scientific advancements.
Developing AI Competencies in Key Sectors
Innovate UK has announced a £2 million competition under its BridgeAI programme aimed at driving innovation in artificial intelligence (AI) across essential sectors in the UK. This initiative seeks to enhance AI competency in the fields of construction, transport and logistics, creative industries, agriculture, and food processing. The competition focuses on fostering responsible and ethical AI-based learning solutions that support upskilling, reskilling, and competency development within these sectors. Here, we explore the programme’s objectives, requirements, and what applicants need to keep in mind to qualify for funding. The competition opens on 11th November with the deadline set at 11am on 29th January 2025.
Objectives of the BridgeAI Programme
The primary goal of the BridgeAI competition is to accelerate the development of AI competencies tailored to specific industry needs. The competition is designed to encourage responsible and ethical approaches to AI education, ensuring that new technologies are not only effective but also aligned with industry standards and values. Proposals submitted to the competition should address how they will meet the following key objectives:
- Accelerating AI Competency Development: Projects should demonstrate how their proposed solutions will enhance AI skills relevant to the sector in a responsible and ethical manner.
- Supporting High-Quality Education: By leveraging evidence-based teaching and learning methodologies, applicants are expected to promote effective learning practices that are aligned with industry standards.
- Aligning with Competency Frameworks: The BridgeAI programme highlights the importance of aligning learning content with both sector-specific standards and the AI Skills for Business Competency Framework to ensure the potential for future accreditation.
- Upskilling and Reskilling the Workforce: Each solution must address the need for upskilling and reskilling existing professionals within the sectors, allowing them to stay current with the latest AI developments.
- Piloting with End Users: Applicants must have a clear plan for piloting their solutions with real-world end users, providing a tangible demonstration of the project’s applicability and effectiveness.
Funding and Project Scope
To be eligible, projects must meet several essential requirements outlined by Innovate UK:
- Eligible Costs and Compliance: The competition offers grants ranging between £50,000 and £100,000 and only eligible project costs should be included in the application.
- Project Duration and Timeline: Projects should have a duration of 6 to 10 months, starting no later than 1st June 2025, and concluding by 31st March 2026.
- Location of Work: All project activities must be carried out in the UK, with the aim to exploit results within the country as well.
- Alignment with Learning Personas: The project must focus on at least one learner type outlined in the AI Skills for Business Competency Framework, including AI Workers, AI Professionals, or AI Leaders, ensuring that solutions are adapted to different levels of experience within the AI landscape.
- Commitment to Diversity and Inclusion: The programme places significant emphasis on promoting equality, diversity, and inclusion, encouraging applicants to design personalised learning journeys that are accessible and fair.
Organisational Requirements
Applicants must be UK-registered businesses of any size, and to be eligible for funding, projects must involve at least one UK-registered micro, small, or medium-sized enterprise (SME). Innovate UK also welcomes collaborations with a variety of UK-registered entities, including academic institutions, charities, non-profits, public sector organisations, and research and technology organizations (RTOs).
In collaborative projects, the lead organization must invite other partners to join the project through the Innovation Funding Service (IFS) platform, where partners will enter their project costs and respond to questions on project impact. Both the lead organisation and any collaborators seeking funding must complete these steps to qualify for the competition.
Portfolio Approach
Innovate UK’s portfolio approach seeks to fund a diverse range of projects, ensuring that the benefits of AI competency development are distributed across various regions and industries. This approach enables Innovate UK to maximise the impact of the BridgeAI programme by investing in innovative solutions across different sectors, meeting the unique needs of each one. Projects that align with the specific themes of AI competency development in key sectors, support diverse learning personas, and uphold inclusive values are particularly valued under this approach.
Specific Themes for Applicants
To align with Innovate UK’s vision for the BridgeAI programme, applicants should ensure their projects address specific themes relevant to the competition:
- Industry-Specific AI Competency Development: Each project must aim to develop AI competencies in at least one of the programme’s target sectors, such as construction, transport and logistics, creative industries, agriculture, or food processing.
- Learner Personas: By focusing on different learner personas within the AI Skills for Business Competency Framework, including AI Workers, Professionals, and Leaders, projects should offer personalised learning pathways that cater to diverse levels of expertise and roles in the industry.
- Promoting Diversity and Inclusion: The competition strongly encourages projects that consider equality, diversity, and inclusion in their learning approaches, thereby ensuring AI competency development is accessible to a broad range of individuals.
Application Tips
Given the competitive nature of this funding opportunity, applicants are encouraged to focus on building a strong case for how their project will accelerate sector-relevant AI competency development while meeting all the programme’s ethical and responsible AI standards. Highlighting clear, evidence-based educational methods, demonstrating an understanding of industry standards, and showing an actionable plan for piloting with end users will increase the chances of selection.
You can read the full competition details here.
The EIC 2025 Work Programme
The European Innovation Council (EIC) unveiled its 2025 Work Programme, highlighting ambitious initiatives designed to solidify Europe’s position as a leader in breakthrough technologies and strengthen its strategic autonomy. By funding high-risk, high-reward innovations, the EIC aims to transform scientific discoveries into market-ready technologies, fostering an environment where innovative companies can thrive and compete globally. This article delves into the essential changes, major highlights, and anticipated impact of the EIC 2025 Work Programme.
1. The New STEP Scale-Up Scheme: Bridging the Funding Gap
One of the centrepieces of the EIC 2025 Work Programme is the newly introduced STEP Scale-Up Scheme. This €300 million initiative is a direct response to the well-documented challenges European deep-tech startups face in securing sufficient growth funding. While Europe has excelled in generating innovative ideas and producing early-stage start-ups, a lack of substantial follow-on funding has limited many companies’ abilities to scale globally.
The STEP Scale-Up Scheme is specifically tailored to address this gap, targeting high-impact companies developing critical technologies. These include digital innovations, clean tech, and biotech solutions - sectors deemed essential for Europe’s competitive and strategic positioning. The scheme will prioritise funding for projects that have a clear path to scale but need significant investment to reach that next level. By doing so, the EIC aims to prevent promising companies from seeking funding outside the EU, which often results in them relocating.
2. Enhanced Focus on Strategic EIC Challenges
The EIC has refined and expanded its EIC Challenges, allocating over €370 million to address pressing global and European priorities. EIC Challenges act as targeted calls for proposals within specific high-potential fields, encouraging innovators to tackle some of the world’s most complex problems. For 2025, the EIC has introduced new and strategically relevant challenges, each designed to push the boundaries of current knowledge and technological capability.
Key areas of focus include:
• Generative Artificial Intelligence (AI): As generative AI continues to disrupt industries, the EIC Challenge in this domain is set to accelerate the development of Europe-centred AI innovations. The goal is to build competitive AI applications that address Europe’s ethical, social, and economic needs, ultimately ensuring Europe’s sovereignty over AI technologies.
• Climate-Resilient Crops: Responding to the urgent need for sustainable agriculture in the face of climate change, this challenge calls for the development of crops that can withstand increasingly extreme weather patterns. Innovations in this space are expected to bolster food security and reduce dependency on external agricultural imports.
• Autonomous Robots for Sustainable Industry: Targeting robotics and automation in industrial settings, this challenge aims to make European industries more sustainable and efficient. By promoting innovations in autonomous robotic systems, the EIC hopes to minimise environmental impact, reduce waste, and create safer working environments.
• Agri-Tech Solutions: Recognising agriculture as a backbone of European sustainability, the EIC is also investing in disruptive agri-tech solutions. These solutions will focus on precision farming, smart sensors, and AI-enabled decision-making tools to support sustainable practices and enhance productivity across European agriculture.
These challenges reflect the EIC’s commitment to addressing both immediate and long-term strategic needs, ensuring that Europe stays at the forefront of technology-driven societal change.
EIC Transition Programme: Bridging Research and Market
The 2025 Work Programme allocates €98 million to the EIC Transition Open, which has no predefined thematic priorities and is open to proposals in any field of science, technology, or application.
The EIC Transition programme is designed to mature novel technologies beyond the experimental proof of principle, facilitating their progression from laboratory settings to real-world applications. It supports single entities or small consortia, including SMEs, start-ups, research organisations, and universities, aiming to validate technologies and develop business plans for specific applications at Technology Readiness Levels (TRL) 3 to 6.
Key features of the EIC Transition include:
• Funding Support: Grants of up to €2.5 million are available to validate and demonstrate technology in application-relevant environments and develop market readiness.
• Booster Grants: Additional booster grants, not exceeding €50,000, are offered for ongoing projects to explore potential commercialization pathways or for portfolio activities.
• Business Acceleration Services (BAS): Beneficiaries gain access to a range of tailor-made BAS, including coaching, mentoring, expertise, training, and connections to global partners and innovation ecosystems.
EIC Accelerator Programme: Scaling Innovations
The EIC Accelerator programme offers €634 million for start-ups and SMEs to develop and scale up innovations with the potential to create new markets or disrupt existing ones. It supports companies aiming to scale up and seeking substantial funding, particularly when the associated risks are too high for private investors alone.
Key components of the EIC Accelerator include:
• Grant Funding: Lump sum contributions below €2.5 million are provided for innovation activities (TRL 6-8), to be completed within 24 months.
• Investment Component: To bridge the gap for high-risk innovations, the programme offers equity investments ranging from €0.5 million to €10 million, with higher amounts available under the STEP Scale-Up scheme. (Not available to UK entities).
• Blended Finance: A combination of grant and equity or quasi-equity (such as convertible loans) is available to support both innovation activities and market deployment.
• Business Acceleration Services (BAS): Similar to the Transition programme, Accelerator beneficiaries have access to BAS, facilitating connections with global partners, coaches, mentors, and innovation ecosystems.
3. Expanded Business Acceleration Services (BAS) for Wider Inclusivity
Recognising that financial support alone isn’t sufficient, the EIC has broadened its Business Acceleration Services (BAS), giving startups and SMEs access to invaluable non-financial resources. This includes mentorship, networking opportunities, and tailored coaching designed to support companies at all stages of growth. The BAS programme will be further expanded in 2025, with an emphasis on reaching underrepresented regions and sectors across the EU.
For the first time, the BAS will specifically target innovators from underrepresented regions, addressing imbalances within the EU’s innovation ecosystem. By providing these innovators with the same level of support available to their counterparts in more established innovation hubs, the EIC aims to create a more balanced and inclusive landscape for European innovation.
Additionally, Seals of Excellence will be awarded to highly promising projects that do not receive EIC funding, guiding them towards alternative European and national funding opportunities. This measure serves to reduce the potential for lost innovation due to limited resources, maximising the impact of the EIC's efforts.
4. The Role of Strategic Autonomy and Sustainability
The EIC 2025 Work Programme places a strong emphasis on strategic autonomy, particularly within sectors deemed critical to Europe’s long-term competitiveness. This includes ensuring that Europe has control over key technologies that could influence its economic independence, such as clean energy solutions, digital innovations, and health-related technologies. By investing in these areas, the EIC aims to reduce Europe’s reliance on non-EU countries for strategic resources and technologies, thereby safeguarding its economic and technological resilience.
Sustainability is also a cornerstone of the 2025 Work Programme. The EIC has aligned its funding strategies with the EU’s broader Green Deal objectives, investing in innovations that promote environmental protection, sustainable resource use, and emissions reduction. In doing so, the EIC supports Europe’s transition to a green economy, ensuring that new technologies contribute positively to the global fight against climate change.
5. Commitment to Research and Innovation Across Key Technology Sectors
The EIC 2025 Work Programme continues its tradition of fostering deep-tech innovation by supporting groundbreaking research and innovation. Deep-tech areas such as quantum computing, advanced materials, and biotechnology remain focal points of the EIC’s funding strategy. These fields have the potential to redefine existing markets and create entirely new ones, driving economic growth and technological leadership within the EU.
In biotechnology, for instance, the EIC has dedicated funding to innovations in gene editing, personalised medicine, and biomanufacturing, areas that could revolutionise healthcare and therapeutics. Similarly, quantum computing is recognised for its potential to transform industries by providing unprecedented computational power, which could support advancements in fields ranging from climate modelling to cryptography.
6. Boosting Public-Private Partnerships and Industry Engagement
A significant aspect of the EIC’s 2025 strategy is encouraging stronger partnerships between the public and private sectors. The Work Programme outlines initiatives to foster collaboration between EIC-funded projects and major industry players, creating pathways for knowledge transfer, co-investment, and broader market access. Through these partnerships, the EIC hopes to fast-track the development and commercialisation of technologies, enabling smaller innovators to access the resources and expertise they need to scale.
In 2025, the EIC will place added emphasis on co-investment schemes, wherein public funding is matched by private sector investment. These co-investment opportunities are intended to mobilise additional financial resources, ensuring that European deep-tech startups have access to the capital required to scale.
You can download the full EIC 2025 Work Programme here.
Mindset extended reality (XR): Digital therapeutics for mental health
Innovate UK has announced a funding opportunity aimed at developing digital therapeutics using extended reality (XR) for mental health. The competition, opening on 28th October 2024, will invest up to £3.7 million in R&D projects that offer innovative mental healthcare solutions. Eligible projects should have costs between £200,000 and £300,000 and last 12 to 18 months. XR solutions should focus on addressing moderate to severe mental health conditions and aim for large-scale adoption within the UK's healthcare system. The deadline for applications is 15th January 2025.
Addressing Mental Health with Extended Reality
Mental health disorders affect millions of people worldwide, and the COVID-19 pandemic has only exacerbated these challenges. The rise in anxiety, depression, and other conditions has spurred the demand for effective mental health treatments that can be scaled and made widely accessible. This funding opportunity encourages the development of XR solutions aimed at treating moderate to severe mental health conditions. XR technologies include virtual reality (VR), augmented reality (AR), and mixed reality (MR), all of which have been used in therapeutic settings for conditions such as post-traumatic stress disorder (PTSD), anxiety, and depression.
By combining these immersive technologies with evidence-based therapeutic approaches, XR solutions can offer patients an engaging and personalised experience. Unlike traditional talk therapies, XR can simulate environments that help patients confront and manage their symptoms in real-time. For instance, VR has been used to treat phobias by gradually exposing individuals to their fears in a controlled and safe environment. Similarly, AR can help users visualise coping strategies or engage with therapeutic content in their daily surroundings.
The Scope of the Competition
The competition invites proposals that will create new, innovative XR-based digital therapeutics. Projects must focus on mental health issues such as depression, anxiety, PTSD, or other moderate to severe conditions. These solutions should not just focus on short-term relief but also demonstrate a potential for long-term, sustainable impact on the UK’s healthcare system.
Innovate UK emphasises the need for solutions that can be integrated into existing healthcare frameworks, allowing for broad scalability and accessibility. This means that proposed XR therapeutics should be designed with the intention of large-scale adoption within the UK’s mental health services. Innovators are encouraged to work closely with healthcare professionals, patients, and mental health experts to ensure that their solutions are evidence-based, patient-centred, and aligned with the needs of the healthcare system.
Eligibility Criteria and Project Requirements
The competition is open to UK-based organisations, including small and medium-sized enterprises (SMEs), large companies, universities, and research and technology organisations. Collaborations between industry and academia are encouraged to foster multidisciplinary approaches, which are often necessary when developing complex digital health solutions. However, lead applicants must demonstrate their ability to lead the development and commercialisation of the proposed XR therapeutic.
Projects should have total costs ranging between £200,000 and £300,000 and are expected to last between 12 and 18 months. This funding can be used to cover a variety of activities, including research and development, clinical trials, user testing, and the creation of XR content. Applicants must show how their solution will meet a significant clinical need, how it will be tested for efficacy and safety, and how it will be positioned for real-world implementation.
Importance of Multidisciplinary Collaboration
Developing effective digital therapeutics requires a multidisciplinary approach, drawing on expertise in healthcare, psychology, technology, and design. The intersection of these fields is crucial for creating XR experiences that are not only technologically sound but also therapeutically effective. For example, clinicians can ensure that the therapeutic content is grounded in psychological science, while XR developers and designers can create immersive and engaging user experiences.
Innovate UK recognises the importance of collaboration between these diverse fields and encourages applicants to assemble teams that reflect this. This includes partnerships between the healthcare sector and technology companies, as well as collaboration with patients and mental health advocates to ensure that the solutions are patient centric. Co-creation with end-users can also help ensure that the final product is user-friendly and meets the needs of those who will benefit from the technology.
Potential Impact on the Healthcare System
The UK’s healthcare system, like many others around the world, is under increasing strain due to rising demand for mental health services. Traditional therapeutic models, which often rely on face-to-face sessions with trained professionals, are resource-intensive and difficult to scale. Digital therapeutics, particularly those that leverage XR, have the potential to fill this gap by offering scalable, accessible, and effective treatments that complement existing care pathways.
XR-based therapeutics can be delivered remotely, allowing patients to engage in therapy from their homes, which can be especially beneficial for those in rural or underserved areas. Moreover, the immersive nature of XR can enhance engagement and adherence to therapy, which are often major barriers to treatment success in mental health. By offering engaging and interactive experiences, XR therapeutics may be more likely to encourage patients to complete their treatment plans and achieve better outcomes.
In addition to benefiting patients, XR solutions have the potential to reduce the burden on healthcare providers. By automating some aspects of treatment or offering supplementary therapeutic content, these solutions could free up clinicians’ time to focus on more complex cases. Furthermore, the data collected through digital therapeutics can provide valuable insights into patient progress, helping clinicians tailor treatments to individual needs.
For more information on how to apply, visit the competition page.
UK’s position on the EU's Research and Innovation Framework Programme
In September 2024, the UK government released a position paper outlining its stance on the EU's upcoming Research and Innovation Framework Programme (FP10). This document highlights the UK's commitment to ongoing collaboration with the EU, focusing on key priorities such as research excellence, global collaboration, security, and the need for reduced administrative burdens. While highlighting the potential benefits of such cooperation, the paper also details the UK’s desire for fair financial contributions and security considerations, setting the stage for future negotiations between the UK and the EU.
Background: The UK's History with EU Research Frameworks
Before delving into the specifics of the UK’s current position, it is essential to understand the history between the UK and the EU in the context of research and innovation collaboration. The EU’s Research and Innovation Framework Programmes, which date back to the 1980s, have always been integral to fostering collaborative research across Europe. Horizon 2020, the predecessor of Horizon Europe, saw the UK as one of the largest beneficiaries and contributors. UK researchers, universities, and businesses often ranked among the top recipients of EU research funding, which allowed them to lead cutting-edge projects and contribute to critical scientific advancements.
However, the UK's decision to leave the EU in 2016 posed significant uncertainties about its future participation in these programs. The post-Brexit Trade and Cooperation Agreement provided a pathway for UK association with Horizon Europe, but the exact terms and conditions were subject to negotiations. The document under review highlights the UK's aspirations to maintain a productive relationship with the EU in the realm of research and innovation, ensuring that Brexit does not lead to scientific isolation.
- Core Objectives of the UK’s Position
The UK government's primary objective in its position on the EU's Research and Innovation Framework Programme is to maintain access to cutting-edge research and innovation networks while safeguarding its own national interests. To achieve this, the document outlines several key goals:
1. Promoting Excellence in Research: The UK emphasises the need for continued participation in programs that prioritise research excellence. The country’s world-leading universities and research institutions have long been central to Europe's research landscape, and the UK aims to retain this role through FP10 (Framework Programme 10). The government stresses that research excellence should remain a cornerstone of EU research programs to ensure that the best minds and institutions can collaborate on solving global challenges.
2. Global Openness and Collaboration: The UK seeks to promote global openness in research. While Europe remains a critical partner, the UK also aspires to expand its research networks to include other countries like the United States, Japan, and Canada. The document advocates for a framework that allows non-EU countries to contribute to and benefit from EU research programs, creating a truly global research ecosystem.
3. Addressing Global Challenges: Tackling issues such as climate change, public health (e.g., pandemic preparedness), and digital transformation are key priorities for the UK. The EU’s Horizon Europe initiative is already aligned with these objectives, and the UK government stresses the importance of continuing to address these global challenges in partnership with the EU and beyond. The position paper highlights that research aimed at solving cross-border problems will be most effective when countries collaborate across geographical boundaries.
4. Security in Research: Given the geopolitical landscape and the increasing importance of data and technology security, the UK insists that any association with EU research programs must consider security issues. This includes protecting sensitive research data, intellectual property, and ensuring that the UK’s national security interests are upheld. The government seeks a balance between open scientific collaboration and safeguarding national security concerns, especially in areas like AI, cybersecurity, and quantum computing.
5. Reducing Administrative Burdens: One of the UK's criticisms of the EU research framework has been its administrative complexity. The UK government advocates for a more streamlined and efficient system that encourages participation from researchers, especially from small and medium-sized enterprises (SMEs). A reduction in bureaucratic red tape would enable smoother collaboration and a more dynamic research environment.
6. Ensuring Value for Money: Post-Brexit, the UK has faced pressure to demonstrate that any financial contributions to EU research programs deliver tangible benefits for its economy and society. The document emphasises that the UK’s participation in FP10 should be based on a fair contribution model where the benefits to the UK are commensurate with its investment. This is crucial in ensuring public support for continued participation in EU initiatives.
Opportunities and Challenges of UK-EU Research Collaboration
The UK’s position on associating with the EU’s Framework Programme reflects both opportunities and challenges. On the one hand, continued collaboration offers substantial benefits. Horizon Europe provides access to some of the world’s most advanced research infrastructures, databases, and networks. UK scientists, universities, and companies would have the opportunity to collaborate with their EU counterparts on groundbreaking projects that are too large or complex to be undertaken by one country alone.
On the other hand, the relationship is not without challenges. The Brexit process has introduced uncertainties around the legal, financial, and operational frameworks governing UK participation in EU programs. There is also the potential for political friction, especially if either side perceives that the terms of collaboration are not mutually beneficial. The UK government, in its position paper, acknowledges these challenges but maintains that constructive negotiations can overcome them.
The Potential Impact on the UK’s Research Ecosystem
Should the UK secure a favourable association agreement with the EU's Research and Innovation Framework Programme, it stands to benefit in several ways. First and foremost, UK researchers will continue to have access to the EU’s vast research networks and funding opportunities. This would be particularly advantageous for fields such as biomedical research, climate science, and artificial intelligence, where collaboration across borders accelerates innovation.
Moreover, the UK’s commitment to global openness means that the country can continue to foster relationships with non-EU partners while benefiting from its proximity to Europe. This dual approach could strengthen the UK's position as a global research hub, attracting top talent and investment from around the world.
However, if the UK fails to secure an agreement or chooses not to participate, the consequences could be significant. UK institutions would lose access to EU funding and collaborative networks, potentially putting them at a disadvantage compared to their European counterparts. This could lead to a “brain drain,” with top researchers opting to work in countries with better funding opportunities. Furthermore, the UK's research output could suffer if it becomes more difficult to participate in large-scale, multinational research projects.
Navigating the Future of UK-EU Research Relations
The UK’s position on the EU’s Research and Innovation Framework Programme reflects a desire for continued collaboration in a post-Brexit world. By prioritising research excellence, global openness, and a fair financial contribution, the UK aims to remain a central player in European and global research networks. The government's stance highlights the need to balance national interests with the benefits of international cooperation, particularly in tackling global challenges that require collective action.
Moving forward, the success of UK-EU research relations will depend on constructive negotiations that address both the opportunities and challenges of collaboration. If managed effectively, the UK could emerge as a stronger, more globally connected research leader, leveraging its relationships with both the EU and the wider world to drive scientific and technological innovation.
For detailed information on the UK's position, you can access the full document here.
Media Cymru's Scale Up Round 2 Funding Competition
The media landscape in Wales is poised for transformational change, and Media Cymru, a dynamic consortium of 22 partner organisations led by Cardiff University, is at the heart of this shift. As part of its ambitious five-year programme, Media Cymru has launched the Scale Up Round 2 funding competition, with support from Innovate UK and the UKRI Strength in Places Fund. With up to £700,000 available to be invested in research and development (R&D) projects, this competition is designed to place the Cardiff Capital Region firmly on the global media stage.
The Vision Behind Media Cymru
Media Cymru is committed to turning the Cardiff Capital Region into a global hub for media production and innovation. However, this transformation is not merely about boosting production capacity. The initiative prioritizes green and fair economic growth, which means creating a sustainable and inclusive media ecosystem where innovation is at the forefront.
The Media Cymru programme revolves around four strategic pillars:
- Green – Reducing the environmental impact of the media sector.
- Fair – Building a diverse, equal, and inclusive sector.
- Global – Expanding international collaborations and partnerships.
- Growth – Fostering economic growth and productivity through R&D and innovation.
Each project funded through this competition is expected to align with at least one of these pillars, ensuring that funded innovations contribute not only to the advancement of the Welsh media industry but also to the wider societal and environmental goals.
Scale Up Round 2: What’s the Opportunity?
Media Cymru: Scale Up Round 2 offers Welsh media companies the chance to secure significant funding for projects with the potential to scale, innovate, and compete on a global stage. The competition will invest in innovation-driven products, services, and experiences that have the ability to transform the media landscape, both locally and internationally.
Key Details:
- Grant funding range: £100,000 to £250,000 per project.
- Project duration: Up to 12 months.
- Deadline: The competition closes at 11am UK time on the 4th December 2024.
- Project start date: Must not begin before 1st April 2025 and should conclude by 30th April 2026.
- Eligibility criteria: Projects must focus on the media sector and demonstrate a tangible economic benefit to the Cardiff Capital Region.
Importantly, applicants must be prepared for a competitive process, as the funding limit means not all high-scoring proposals will necessarily be funded.
What Makes a Winning Proposal?
Success in this competition hinges on a company’s ability to present a project that meets the specific requirements of the competition while standing out in terms of innovation and scalability.
Here’s what the competition is looking for in a winning proposal:
- Innovation-Driven Solutions: Your project must aim to solve a key challenge or seize an opportunity within the Welsh media industry. Whether it’s improving media production processes, creating innovative content platforms, or addressing challenges related to digital consumption, the project should be original and impactful.
- Proven Feasibility: Ideas are not enough on their own. You need to demonstrate the feasibility of your innovation. This means that the technology or solution you propose must have a sound basis for development and implementation, supported by clear evidence or research.
- Economic Impact: A core goal of this competition is to drive economic growth in the Cardiff Capital Region. Successful applicants will need to demonstrate how their innovation will contribute to the local economy by creating jobs, increasing productivity, or attracting additional investment.
- Rapid Commercialisation: The competition is not just about ideas; it’s about turning those ideas into tangible products and services that can be rapidly commercialised. Your proposal should include a clear commercialisation strategy, detailing how your innovation will be brought to market quickly and effectively after the project’s completion.
- Knowledge Sharing: Collaboration and knowledge-sharing are fundamental to Media Cymru’s vision. Applicants are expected to actively share knowledge and project outputs with the broader media community, fostering a culture of innovation across the region.
- Alignment with Strategic Pillars: Every project must align with one or more of Media Cymru’s strategic pillars (Green, Fair, Global, Growth). This ensures that your innovation contributes to the overarching goals of the programme, whether that’s through promoting sustainability, increasing diversity, driving international partnerships, or enhancing regional economic growth.
Why Should Welsh Media Companies Apply?
The Media Cymru Scale Up Round 2 competition presents a unique opportunity for media companies in the Cardiff Capital Region to receive significant financial backing for their most ambitious and innovative projects. However, the benefits extend far beyond funding.
- Enhanced Visibility and Prestige
Being selected for funding through this competition positions your company as an industry leader. It showcases your commitment to innovation and your ability to develop solutions that can compete on the global stage. This visibility can lead to further collaborations, partnerships, and investment opportunities. - Global Reach
Media Cymru’s commitment to international collaboration means that companies funded through this programme will have the chance to build relationships with global partners, expanding their reach and influence beyond the Welsh and UK markets. - Driving Positive Change
By aligning your project with Media Cymru’s strategic pillars, you’re contributing to a more sustainable, diverse, and innovative media sector. Whether it’s reducing the carbon footprint of media production or creating a more inclusive industry, your project can be part of shaping the future of media in Wales and beyond. - Economic Impact
Perhaps most importantly, successful projects will play a pivotal role in driving economic growth in the Cardiff Capital Region. By creating new jobs, attracting investment, and increasing productivity, your project can have a lasting positive impact on the region’s economy.
Biomedical Catalyst 2024 Now Open
Innovate UK has announced the next round of its Biomedical Catalyst (BMC) competition, offering up to £15 million in funding for innovation projects aimed at addressing critical health and healthcare challenges. This industry-led R&D initiative provides a valuable opportunity for small and medium-sized enterprises (SMEs) to develop cutting-edge solutions, spanning from disease prevention to digital health technologies.
Focus Areas of the Competition
The competition is designed to foster innovation across a wide range of health-related areas. Projects are encouraged to focus on one or more of the following:
• Disease Prevention and Management: Projects that develop proactive strategies for managing health and chronic conditions, with the goal of improving long-term health outcomes.
• Early Detection and Diagnosis: Innovations that allow for faster, more accurate detection of diseases, leading to more effective treatments and better patient outcomes.
• Tailored Treatments and Cures: Research aimed at personalising treatments that target the root causes of diseases or offer potential cures for conditions that currently have limited treatment options.
• Transforming Healthcare Delivery: Projects that focus on improving the efficiency and effectiveness of healthcare systems, making them more accessible and responsive.
• Development of Digital Health Technologies: The advancement of digital tools to enhance patient care, monitoring, and self-care.
• Consumer-Focused Self-Care: Innovations that empower individuals to take charge of their health and well-being through accessible, consumer-focused products.
This broad scope ensures that a wide range of health and healthcare innovations can be supported through the competition, from cutting-edge biotechnology to revolutionary digital health platforms.
Eligibility Criteria for Projects
To qualify for the BMC competition, projects must meet several key criteria. First and foremost, projects must demonstrate evidence of both commercial and technical feasibility. This ensures that proposed solutions have a strong chance of reaching the market and making a tangible impact on healthcare systems.
Additionally, each project must:
• Have total project costs between £150,000 and £4 million.
• Not exceed a grant request of £2 million.
• Ensure that at least 50% of the project costs are covered by the SMEs if it’s a collaborative project.
• Be completed within a timeframe of 6 to 36 months.
• Be carried out entirely within the UK and aim to exploit results in the UK.
• Begin no later than 1st May 2025 and finish by 30th September 2028.
Lead Organisations and Project Teams
To lead a project, the organisation must be a UK-registered micro, small, or medium-sized enterprise (SME). This SME can either work alone or in collaboration with other UK-based organisations, including businesses of any size, academic institutions, charities, public sector organisations, and research and technology organisations (RTOs). Notably, academic institutions are not permitted to lead projects but can serve as collaborators.
Types of Eligible Projects
The competition supports a wide variety of R&D activities, from early-stage experimental research to the development and testing of new products. Eligible projects can include:
• Experimental Evaluation: Testing new solutions on a laboratory scale or using in vitro and in vivo models to evaluate proof of concept or safety.
• Prototyping and Product Development: Moving ideas from concept to prototype, and ultimately, to market-ready products.
• Clinical Trials: Demonstrating clinical utility, safety, and efficacy through early-phase (Phase 1 and 2) clinical trials.
• Regulatory Planning: Preparing for regulatory approval by engaging with relevant bodies early in the development process.
These projects should demonstrate how they can address significant health challenges while also improving the productivity and competitiveness of the SMEs involved.
Supporting a Portfolio of Projects
Innovate UK aims to fund a diverse portfolio of projects across different technologies and themes. This approach ensures that a wide range of innovative solutions have the opportunity to receive funding and make a meaningful impact on the UK’s healthcare sector.
Specific themes that the competition encourages include, but are not limited to:
• Advanced Therapies: Such as gene and cell therapies that represent the cutting edge of personalised medicine.
• Biosciences and Preclinical Technologies: Exploring new drug targets and mechanisms before they enter clinical trials.
• Medical Technology and Devices: Developing new tools for diagnosing and treating diseases.
• Digital Health: Pioneering new platforms and technologies that transform healthcare delivery, enhance remote monitoring, or improve patient outcomes.
• Independent Living: Supporting technologies that enable individuals, particularly those with chronic conditions or disabilities, to live more independently.
Competition Process
The BMC competition is a competitive process, meaning that not all projects will receive funding, even if they score highly. The competition closes at 11am on Wednesday, 16th October 2024. Projects that request grants of over £500,000 may be required to attend an interview as part of the assessment process.
Applicants are encouraged to review the specific details of the competition through the Innovate UK competition brief to ensure they are submitting the most accurate and relevant information: Biomedical Catalyst 2024 Round 1: Industry-led R&D
Travel support for UK businesses to attend European events
Innovate UK has launched a travel support scheme designed to assist small and medium-sized enterprises (SMEs) in the UK in expanding their reach into European research and development (R&D) collaborations. This initiative, set to run throughout the second half of 2024, provides funding to enable SMEs to attend key European events focused on R&D and consortia-building.
Following the UK’s renewed association with Horizon Europe, this travel support aims to bolster international collaboration by ensuring that UK businesses remain visible and active participants in European research initiatives. SMEs are the backbone of innovation, and this initiative offers them a unique opportunity to expand their networks, secure partnerships, and contribute to major collaborative projects across the continent.
The industries covered under this initiative are wide-ranging, including space technology, sustainable urban mobility, and hydrogen energy, among others. Each event offers a platform for SMEs to engage with international counterparts, forming partnerships that could lead to new research breakthroughs and technological advancements.
One of the key benefits of this program is its role in removing financial barriers for UK businesses. Travel and accommodation costs can be prohibitive, particularly for smaller enterprises. Innovate UK's travel support offers up to £700 per company to cover these costs, enabling more businesses to participate in high-impact events without the burden of additional financial strain.
This initiative is viewed as a strategic tool to ensure that UK businesses remain at the forefront of global research collaborations. As Europe’s R&D landscape continues to evolve, especially with the Horizon Europe program driving significant funding and opportunities, it’s essential that UK SMEs are not left behind. By facilitating their involvement in European consortia, this initiative helps ensure that the UK remains a leader in research and innovation.
For more information, please visit: https://iuk.ktn-uk.org/news/travel-support-now-available/
Sustainable Medicines Manufacturing Initiative
The pharmaceutical industry has long been associated with high energy consumption and waste. In response, Innovate UK, in collaboration with the Department of Health and Social Care (DHSC), has launched a new initiative aimed at promoting sustainable practices in the manufacturing of medicines. This £15 million program, opening for applications with a deadline of 16th October 2024, is set to drive innovation and greener technologies across the pharmaceutical sector.
The aim of this competition is to drive innovation in sustainable medicines manufacturing across three key pillars:
• green chemistry
• circularity
• productivity and resource efficiency
Projects must also consider both critical enablers:
• regulations: how to overcome any regulatory barriers to adoption of your innovation.
• measurements, standards and data: approaches to capture data that support the measurement and reporting of sustainability indicators aligned with industry standards.
These new manufacturing innovations are expected to support more environmentally sustainable manufacturing processes with significant and measurable improvements in at least one of the following areas:
• productivity
• waste reduction
• emissions reduction
• energy use reduction
• resource efficiency
Funding must be used to invest in innovation to deliver across four key goals:
• drive disruptive and novel technologies or processes in medicines manufacturing to optimise production efficiency, minimise waste and reduce emissions, aligning with global sustainability goals
• facilitate the effective implementation of innovative solutions and promote their adoption across the medicines manufacturing sector, ensuring scalability and widespread utilisation
• enhance the UK’s attractiveness as a prime location for investment in medicines manufacturing, thereby stimulating economic growth and enhancing resilience in the sector
• strengthen the UK's manufacturing innovation ecosystem through collaborative partnerships between academia, industry, and government entities, promoting knowledge exchange and collaborative initiatives to enhance sustainable manufacturing practices
Projects must also consider how to overcome any regulatory barriers to adoption of the innovation, alongside approaches to capture data that support the measurement and reporting of sustainability indicators aligned with industry standards. By fostering collaboration between researchers, innovators, and manufacturers, this initiative hopes to accelerate the adoption of cutting-edge solutions that can be implemented quickly. The aim is to see tangible impact within three years of project completion, meaning that the results of these investments should be felt before the end of the decade.
Innovators interested in applying for the funding will have the opportunity to develop and commercialise technologies that can significantly transform medicine manufacturing processes while contributing to broader environmental goals.
DASA's Rapid Impact Open Call Returns
The Defence and Security Accelerator’s (DASA) Rapid Impact Open Call is back after a five-month pause, and Cycle 3 is now open for applications. This cycle seeks innovative solutions to defence challenges with a clear impact within three years of project completion. Proposals should be valued between £150,000 and £250,000 and aim to reach Technology Readiness Level (TRL) 6/7 by the project's end. The deadline for submissions is 19th November 2024.
Before applying, it's essential to contact your local innovation partner.
Competition Document
Contact your Innovation Partner